As announced by DSM and Firmenich on November 22, 2022, following the announcement of their merger of equals on May 31, 2022, the Company launched a voluntary public exchange offer for all the issued and outstanding ordinary shares in DSM’s share capital (the “DSM Ordinary Shares”) (the “Exchange Offer”). Final results of the Exchange Offer were announced on May 1, 2023, with 96.1% of the DSM Ordinary Shares having been tendered in the Exchange Offer, and the merger of equals successfully completed on May 8, 2023.
As a result, and as announced on May 1, 2023, the Company has commenced the buy-out procedure in accordance with Dutch law in order to acquire the DSM Ordinary shares that have not been tendered in the Exchange Offer (the “Buy-Out”), and will terminate the listing and trading of the DSM Ordinary Shares on Euronext Amsterdam, effective from May 31, 2023. Under the envisaged Buy-Out, any remaining holders of DSM Ordinary Shares (other than the Company) will receive a cash consideration.
To fund the cash consideration payable by the Company in relation to the Buy-Out, DSM, Firmenich and the Company have agreed to sell a certain number of DSM-Firmenich ordinary shares prior to the end of 2023. This sale will be done through the Share Placement. For more visit dsm-firmenich.com
